Eric Crombez, EVP and Chief Medical Officer, made open market sales of ABEO (Abeona Therapeutics Inc.) shares twice in the last year, totaling about $116 thousand, with the latest on February 2, 2026. He ranks 9,358th among insiders for ABEO sales. For RARE (Ultragenyx Pharmaceutical Inc.), he sold three times for around $189 thousand, most recently on March 2, 2026, ranking 8,532nd. With no purchases recorded, his total sales trail the average insider's nearly $8.6 million across 6.4 transactions among over 11,600 individuals.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 7029 | $22.80 | 76,301.0000 | 98,600,000 | 8.44% | 0.01% |
| March 1, 2026 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Common Stock | 11643 | $0.00 | 83,173.0000 | 98,600,000 | 16.28% | 0.01% |
| Feb. 2, 2026 | ABEONA THERAPEUTICS INC. | $ABEO | Crombez Eric | Director | S | Common Stock | 16284 | $5.09 | 63,456.0000 | 65,780,650 | 20.42% | 0.02% |
| Jan. 26, 2026 | ABEONA THERAPEUTICS INC. | $ABEO | Crombez Eric | Director | A | Common Stock | 37313 | $0.00 | 79,740.0000 | 65,780,650 | 87.95% | 0.06% |
| Aug. 14, 2025 | ABEONA THERAPEUTICS INC. | $ABEO | Crombez Eric | Director | S | Common Stock | 4718 | $6.93 | 42,427.0000 | 41,048,206 | 10.01% | 0.01% |
| May 5, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 520 | $39.24 | 71,530.0000 | 90,538,118 | 0.72% | 0.00% |
| April 21, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 242 | $35.11 | 71,680.0000 | 90,538,118 | 0.34% | 0.00% |
| March 1, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Common Stock | 14971 | $0.00 | 80,215.0000 | 90,538,118 | 22.95% | 0.02% |
| March 3, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 8945 | $42.10 | 71,922.0000 | 90,538,118 | 11.06% | 0.01% |
| March 1, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Stock Ooption (Right to Buy) | 30246 | $0.00 | 30,246.0000 | 90,538,118 | 9999.99% | 0.03% |
| March 1, 2025 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Common Stock | 16813 | $0.00 | 65,244.0000 | 90,538,118 | 34.72% | 0.02% |
| Jan. 31, 2025 | ABEONA THERAPEUTICS INC. | $ABEO | Crombez Eric | Director | A | Common Stock | 36101 | $0.00 | 47,145.0000 | 41,048,206 | 326.88% | 0.09% |
| Aug. 13, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Crombez Eric | Director | A | Common Stock | 11044 | $0.00 | 11,044.0000 | 21,380,476 | 9999.99% | 0.05% |
| May 2, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 354 | $43.66 | 48,431.0000 | 73,543,862 | 0.73% | 0.00% |
| April 18, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 142 | $44.10 | 48,785.0000 | 73,543,862 | 0.29% | 0.00% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Common Stock | 19400 | $0.00 | 49,912.0000 | 73,543,862 | 63.58% | 0.03% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | S | Common Stock | 1238 | $53.76 | 48,927.0000 | 73,543,862 | 2.47% | 0.00% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Stock Option (Right to Buy) | 34200 | $0.00 | 34,200.0000 | 73,543,862 | 9999.99% | 0.05% |
| March 1, 2024 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Stock Option (Right to Buy) | 2351 | $0.00 | 2,351.0000 | 73,543,862 | 9999.99% | 0.00% |
| Sept. 27, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Stock Option (Right to Buy) | 2351 | $0.00 | 2,351.0000 | 69,914,225 | 9999.99% | 0.00% |
| May 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Stock Option (Right to Buy) | 8362 | $0.00 | 8,362.0000 | 69,914,225 | 9999.99% | 0.01% |
| May 1, 2023 | Ultragenyx Pharmaceutical Inc. | $RARE | Crombez Eric | EVP and Chief Medical Officer | A | Common Stock | 4658 | $0.00 | 30,512.0000 | 69,914,225 | 18.02% | 0.01% |